Simplex Trading, LLC Bio Atla, Inc. Transaction History

Simplex Trading, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$1.88 - $3.46 $58,868 - $108,342	31,313 Added 262.56%	43,239 $148,000
Q4 2023 Feb 02, 2024	SELL	$1.27 - $3.18 $32,480 - $81,328	-25,575 Reduced 68.2%	11,926 $29,000
Q3 2023 Nov 01, 2023	BUY	$1.7 - $3.07 $63,751 - $115,128	37,501 New	37,501 $63,000
Q1 2023 Apr 27, 2023	SELL	$2.3 - $8.25 $20,621 - $73,969	-8,966 Reduced 82.83%	1,858 $4,000
Q4 2022 Feb 02, 2023	BUY	$6.29 - $11.01 $53,873 - $94,300	8,565 Added 379.15%	10,824 $89,000
Q3 2022 Nov 04, 2022	SELL	$2.94 - $11.87 $62,363 - $251,786	-21,212 Reduced 90.38%	2,259 $17,000
Q2 2022 Aug 03, 2022	BUY	$2.13 - $5.38 $26,017 - $65,716	12,215 Added 108.52%	23,471 $66,000
Q1 2022 May 02, 2022	BUY	$4.38 - $18.78 $11,839 - $50,762	2,703 Added 31.6%	11,256 $56,000
Q4 2021 Feb 23, 2022	BUY	$19.0 - $30.95 $162,507 - $264,715	8,553 New	8,553 $167,000

22.1M

10.7K

7.4K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $59.2M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.